4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Vaccine: new trials by email Literature Review of Vaccine trials Research Report on Vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PFAS Exposure and Immune Response to Vaccination in Adults TENIVAC - Innate Inflammatory Response, Vaccination | Phase 4 | Completed | Rutgers, The State University of New Jersey | 20 | 2024-11-04 | 2025-12-30 |
| Effects of Shotblocker® and Manual Pressure on Pain Shotblocker, Manuel Pressure - Healthy Volunteers, Infant | Phase 4 | Completed | Aydin Adnan Menderes University | 102 | 2022-02-15 | 2025-02-07 |
| Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live Measles, Mumps and Rubella Combined Vaccine, Live - Immunotoxicity, Vaccine | Phase 4 | Completed | Shanghai Institute Of Biological Products | 1068 | 2021-12-23 | 2023-08-14 |
| Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions Cell-derived influenza vaccine, Egg-derived influenza vaccine - Seasonal Influenza, Vaccine | Phase 4 | Completed | Novartis Vaccines | 1398 | 2007-11-01 | 2016-02-17 |
Diphtheria (1) · Inflammation (1) · Influenza, Human (1) · Pain (1) · Tetanus (1)
Infections (2) · Pathological Conditions, Signs and Symptoms (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Clostridium Infections (1) · Corynebacterium Infections (1) · Gram-Positive Bacterial Infections (1) · Neurologic Manifestations (1) · Orthomyxoviridae Infections (1) · Pathologic Processes (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Signs and Symptoms (1)
Diphtheria-Tetanus Vaccine (1) · Tetanus Toxoid (1)
Aydin Adnan Menderes University (1) · Novartis Vaccines (1) · Rutgers, The State University of New Jersey (1) · Shanghai Institute Of Biological Products (1)
China (1) · Germany (1) · Turkey (Türkiye) (1) · United States (1)
Hongxing Pan (1) · Robert Laumbach, MD (1)